Mayne Pharma Group Limited MYX.AX Stock
Mayne Pharma Group Limited Price Chart
Mayne Pharma Group Limited MYX.AX Financial and Trading Overview
Mayne Pharma Group Limited stock price | 6.96 AUD |
Previous Close | 3.86 AUD |
Open | 3.87 AUD |
Bid | 3.89 AUD x 0 |
Ask | 3.92 AUD x 0 |
Day's Range | 3.75 - 3.91 AUD |
52 Week Range | 2.68 - 8.5 AUD |
Volume | 244.84K AUD |
Avg. Volume | 332.08K AUD |
Market Cap | 331.79M AUD |
Beta (5Y Monthly) | 0.992337 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -3.18 AUD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | January 18, 2023 |
1y Target Est | 4.34 AUD |
MYX.AX Valuation Measures
Enterprise Value | 264.84M AUD |
Trailing P/E | N/A |
Forward P/E | -6.964286 |
PEG Ratio (5 yr expected) | 0.37 |
Price/Sales (ttm) | 0.8834441 |
Price/Book (mrq) | 0.4311298 |
Enterprise Value/Revenue | 0.705 |
Enterprise Value/EBITDA | -3.129 |
Trading Information
Mayne Pharma Group Limited Stock Price History
Beta (5Y Monthly) | 0.992337 |
52-Week Change | -17.87% |
S&P500 52-Week Change | 20.43% |
52 Week High | 8.5 AUD |
52 Week Low | 2.68 AUD |
50-Day Moving Average | 3.9 AUD |
200-Day Moving Average | 4.36 AUD |
MYX.AX Share Statistics
Avg. Volume (3 month) | 332.08K AUD |
Avg. Daily Volume (10-Days) | 298.2K AUD |
Shares Outstanding | 85.07M |
Float | 60.52M |
Short Ratio | N/A |
% Held by Insiders | 24.82% |
% Held by Institutions | 16.47% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | June 30, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | June 30, 2023 |
Profitability
Profit Margin | 20.51% |
Operating Margin (ttm) | -39.92% |
Gross Margin | 30.43% |
EBITDA Margin | -22.53% |
Management Effectiveness
Return on Assets (ttm) | -6.32% |
Return on Equity (ttm) | -43.54% |
Income Statement
Revenue (ttm) | 375.56M AUD |
Revenue Per Share (ttm) | 4.53 AUD |
Quarterly Revenue Growth (yoy) | -32.70% |
Gross Profit (ttm) | 171.03M AUD |
EBITDA | -84641000 AUD |
Net Income Avi to Common (ttm) | -326335008 AUD |
Diluted EPS (ttm) | -4.05 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 175.54M AUD |
Total Cash Per Share (mrq) | 1.99 AUD |
Total Debt (mrq) | 81.23M AUD |
Total Debt/Equity (mrq) | 10.18 AUD |
Current Ratio (mrq) | 1.454 |
Book Value Per Share (mrq) | 9.046 |
Cash Flow Statement
Operating Cash Flow (ttm) | -64414000 AUD |
Levered Free Cash Flow (ttm) | -150407872 AUD |
Profile of Mayne Pharma Group Limited
Country | Australia |
State | SA |
City | Salisbury South |
Address | 1538 Main North Road |
ZIP | 5106 |
Phone | 61 8 8209 2666 |
Website | https://www.maynepharma.com |
Industry | Drug Manufacturers-General |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. It provides oral drug delivery systems; and contract pharmaceutical development, manufacturing, and analytical services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.
Q&A For Mayne Pharma Group Limited Stock
What is a current MYX.AX stock price?
Mayne Pharma Group Limited MYX.AX stock price today per share is 6.96 AUD.
How to purchase Mayne Pharma Group Limited stock?
You can buy MYX.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Mayne Pharma Group Limited?
The stock symbol or ticker of Mayne Pharma Group Limited is MYX.AX.
Which industry does the Mayne Pharma Group Limited company belong to?
The Mayne Pharma Group Limited industry is Drug Manufacturers-General.
How many shares does Mayne Pharma Group Limited have in circulation?
The max supply of Mayne Pharma Group Limited shares is 85.07M.
What is Mayne Pharma Group Limited Price to Earnings Ratio (PE Ratio)?
Mayne Pharma Group Limited PE Ratio is now.
What was Mayne Pharma Group Limited earnings per share over the trailing 12 months (TTM)?
Mayne Pharma Group Limited EPS is -3.18 AUD over the trailing 12 months.
Which sector does the Mayne Pharma Group Limited company belong to?
The Mayne Pharma Group Limited sector is Healthcare.
Mayne Pharma Group Limited MYX.AX included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
S&P/ASX SMALL ORDINARIES AXSO | 3055.7 AUD 2022.44 USD |
-0.94
|
— — | 3042.1 AUD 2013.44 USD | 3084.6 AUD 2041.56 USD | — - | — — |
ALL ORDINARIES AORD | 8014.4 AUD 5304.39 USD |
-0.44
|
— — | 7991.2 AUD 5289.03 USD | 8050.6 AUD 5328.35 USD | — - | — — |
NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN | 1704.47 GBP 2179.91 USD |
0
|
— — | 1704.47 GBP 2179.91 USD | 1704.47 GBP 2179.91 USD | — - | — — |
S&P/ASX 300 AXKO | 7711.3 AUD 5103.78 USD |
-0.4
|
— — | 7688.2 AUD 5088.49 USD | 7743.1 AUD 5124.83 USD | — - | — — |
- {{ link.label }} {{link}}